AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY for AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
7/10/2024: Sign-on letter to Chair and Ranking Member of Senate Committee on Appropriations, Subcommittee on State, Foreign Operations, and Related Programs in support on $10 million for Neglected Surgical Conditions for FY2025. Outlines health and longevity benefits of supporting surgical interventions through low-and-middle-income counties (LMICs). 7/23/2024: Sign-on letter to House Speaker, House Minority Leader, Senate Majority Leader, and Senate Minority Leader in opposition to the Equitable Community Access to Pharmacist Services Act (H.R. 1770/S. 2477); includes issues related to scope of practice, patient care, physician education and training, and the CBO scoring system. 7/24/2024: Sign-on letter to House Speaker, House Minority Leader, Senate Majority Leader, and Senate Minority Leader in support of the Strengthening Medicare for Patients and Providers Act (H.R. 2474), the Provider Reimbursement Stability Act (H.R. 6371), and the Value in Health Care (VALUE) Act (H.R. 5013/S.3503); issues related to the Medicare Access and CHIP Reauthorization Act (MACRA), inflationary updates to the Medicare Physician Fee Schedule, reforms to budget neutrality laws, reforms to MACRA's Merit-based Incentive Payment System (MIPS), and changes to Alternative Payment Models (APMs). 7/29/2024: Letter to Reps. Burgess, Cardenas, Griffith, and Gonzalez in support of the Physician Led and Rural Access to Quality Care Act (H.R. 9001); issues related to patient access to care, healthcare innovation and competition, and physician ownership of healthcare facilities. 8/21/2024: Coalition letter to Director of the Division of Services for Children with Special Health Needs at the Maternal and Child Health Bureau of the HRSA regarding changes to the funding structure of state Early Hearing Detection Intervention (EHDI) programs. Letter urges Director to ensure new structure ensures continued excellence and supports stated aims to improve children lost to follow-up (LTF) in these programs, screen three-year-olds, utilize new gene therapies, meet existing benchmark for referrals, and other quality metrics. 9/4/2024: Letter to Sens. Boozman, Welch, Tillis, King, Marshall, and Shaheen in support of the Physician Fee Stabilization Act (S. 4935); issues related to the Medicare Physician Fee Schedule and the Medicare Economic Index. 9/10/2024: Sign-on letter to House Speaker, House Minority Leader, Senate Majority Leader, and Senate Minority Leader in support of the Strengthening Medicare for Patients and Providers Act (H.R. 2474), the Provider Reimbursement Stability Act (H.R. 6371), and the Physician Fee Stabilization Act (S. 4935); issues related to the Medicare physician payment system and inflationary impacts on the Medicare Physician Fee Schedule. 9/13/2024: Sign-on letter to Congress in support of the Physician Led and Rural Access to Quality Care Act (H.R. 9001); issues related to physician ownership of hospitals in needy areas and rural access to quality healthcare services. Issues related to hearing healthcare, in general. Issues pertaining to health information technology and electronic health records, in general. Issues pertaining to Graduate Medical Education, in general. Issues pertaining to healthcare liability reform, in general. Issues pertaining to prior authorization, the Improving Seniors Timely Access to Care Act (S. 4532 /H.R. 8702), and in general. Issues pertaining to Medicare physician reimbursement, related to the Strengthening Medicare for Patients and Providers Act (H.R. 2474) and the Preserving Seniors Access to Physicians Act of 2023 (H.R. 6683), and in general. Issues pertaining to Medicare allergy verification, the Penicillin Allergy Verification and Evaluation Act of 2024 (H.R. 9778), and in general.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN AGUILAR | — |
| HARRY DECABO | — |
| MAURA FARRELL | — |
Medicare/Medicaid MMM
7/24/2024: Sign-on letter to House Speaker, House Minority Leader, Senate Majority Leader, and Senate Minority Leader in support of the Strengthening Medicare for Patients and Providers Act (H.R. 2474), the Provider Reimbursement Stability Act (H.R. 6371), and the Value in Health Care (VALUE) Act (H.R. 5013/S.3503); issues related to the Medicare Access and CHIP Reauthorization Act (MACRA), inflationary updates to the Medicare Physician Fee Schedule, reforms to budget neutrality laws, reforms to MACRA's Merit-based Incentive Payment System (MIPS), and changes to Alternative Payment Models (APMs). 9/4/2024: Letter to Sens. Boozman, Welch, Tillis, King, Marshall, and Shaheen in support of the Physician Fee Stabilization Act (S. 4935); issues related to the Medicare Physician Fee Schedule and the Medicare Economic Index. 9/10/2024: Sign-on letter to House Speaker, House Minority Leader, Senate Majority Leader, and Senate Minority Leader in support of the Strengthening Medicare for Patients and Providers Act (H.R. 2474), the Provider Reimbursement Stability Act (H.R. 6371), and the Physician Fee Stabilization Act (S. 4935); issues related to the Medicare physician payment system and inflationary impacts on the Medicare Physician Fee Schedule. Issues pertaining to Medicare allergy verification, the Penicillin Allergy Verification and Evaluation Act of 2024 (H.R. 9778), and in general. Issues related to hearing healthcare, in general. Issues pertaining to step therapy, in general. Issues pertaining to health information technology and electronic health records, in general. Issues pertaining to Graduate Medical Education, in general. Issues pertaining to healthcare liability reform, in general
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN AGUILAR | — |
| HARRY DECABO | — |
| MAURA FARRELL | — |
Tobacco TOB
Issues pertaining to tobacco control, including the pending FDA rule on prohibiting menthol cigarettes, and in general.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN AGUILAR | — |
| HARRY DECABO | — |
| MAURA FARRELL | — |
Budget/Appropriations BUD
7/10/2024: Sign-on letter to Chair and Ranking Member of Senate Committee on Appropriations, Subcommittee on State, Foreign Operations, and Related Programs in support on $10 million for Neglected Surgical Conditions for FY2025. Outlines health and longevity benefits of supporting surgical interventions through low-and-middle-income counties (LMICs). 7/23/2024: Sign-on letter to House Speaker, House Minority Leader, Senate Majority Leader, and Senate Minority Leader in opposition to the Equitable Community Access to Pharmacist Services Act (H.R. 1770/S. 2477); includes issues related to scope of practice, patient care, physician education and training, and the CBO scoring system. 7/24/2024:Sign-on letter to House Speaker, House Minority Leader, Senate Majority Leader, and Senate Minority Leader in support of the Strengthening Medicare for Patients and Providers Act (H.R. 2474), the Provider Reimbursement Stability Act (H.R. 6371), and the Value in Health Care (VALUE) Act (H.R. 5013/S.3503); issues related to the Medicare Access and CHIP Reauthorization Act (MACRA), inflationary updates to the Medicare Physician Fee Schedule, reforms to budget neutrality laws, reforms to MACRA's Merit-based Incentive Payment System (MIPS), and changes to Alternative Payment Models (APMs). 9/4/2024: Letter to Sens. Boozman, Welch, Tillis, King, Marshall, and Shaheen in support of the Physician Fee Stabilization Act (S. 4935); issues related to the Medicare Physician Fee Schedule and the Medicare Economic Index. 9/10/2024: Sign-on letter to House Speaker, House Minority Leader, Senate Majority Leader, and Senate Minority Leader in support of the Strengthening Medicare for Patients and Providers Act (H.R. 2474), the Provider Reimbursement Stability Act (H.R. 6371), and the Physician Fee Stabilization Act (S. 4935); issues related to the Medicare physician payment system and inflationary impacts on the Medicare Physician Fee Schedule. Issues pertaining to Medicare allergy verification, the Penicillin Allergy Verification and Evaluation Act of 2024 (H.R. 9778), and in general. Issues pertaining to the budget and appropriations, in general.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN AGUILAR | — |
| HARRY DECABO | — |
| MAURA FARRELL | — |
Veterans VET
Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN AGUILAR | — |
| HARRY DECABO | — |
| MAURA FARRELL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.